The Pathway to a Universal Influenza Vaccine

Development of a universal influenza vaccine is a research priority for the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. To facilitate this goal, we convened a workshop in Rockville, Maryland to identify knowledge gaps in influenza research and...

Full description

Saved in:
Bibliographic Details
Published in:Immunity (Cambridge, Mass.) Mass.), 2017-10, Vol.47 (4), p.599-603
Main Authors: Paules, Catharine I., Marston, Hilary D., Eisinger, Robert W., Baltimore, David, Fauci, Anthony S.
Format: Article
Language:English
Subjects:
Allergies
Animals
Disease Models, Animal
Ferrets
Humans
Infectious diseases
Influenza
Influenza A virus - immunology
Influenza Vaccines - administration & dosage
Influenza Vaccines - immunology
Influenza, Human - immunology
Influenza, Human - prevention & control
Influenza, Human - virology
National Institute of Allergy and Infectious Diseases (U.S.)
Pandemics
Studies
United States
Vaccines
Viruses
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Development of a universal influenza vaccine is a research priority for the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. To facilitate this goal, we convened a workshop in Rockville, Maryland to identify knowledge gaps in influenza research and develop strategies to fill them. Development of a universal influenza vaccine is a research priority for the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. To facilitate this goal, we convened a workshop in Rockville, Maryland to identify knowledge gaps in influenza research and develop strategies to fill them.
ISSN:1074-7613
1097-4180
DOI:10.1016/j.immuni.2017.09.007